Clinical trial · Observational
The Genotype and Phenotype of Lymphangioleiomyomatosis
NCT06405997CI-TRIAL-00076976recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to differentiate between sporadic Lymphangioleiomyomatosis and Tuberous Sclerosis Complex-associated Lymphangioleiomyomatosis.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Sporadic Lymphangioleiomyomatosis | — | UNRESOLVED | — |
| TSC-associated Lymphangioleiomyomatosis | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- The genotype and phenotype of lymphangioleiomyomatosis
- timeFrame
- one month
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * age ≥ 18 y/o * Patient with Chest CT showed cystic lung disease, suspected Lymphangioleiomyomatosis Exclusion Criteria: * age \< 18 y/o
References
Publications (0)
Data not yet available
No reference posted for this study.